<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>CurrentAnesthesia — Anaesthetic drugs &amp; techniques</title>
<subtitle>The newest Briefs placed in Anaesthetic drugs &amp; techniques.</subtitle>
<id>https://currentanesthesia.com/topics/anaesthetic-drugs-techniques/feed.xml</id>
<link rel="self" type="application/atom+xml" href="https://currentanesthesia.com/topics/anaesthetic-drugs-techniques/feed.xml"/>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/topics/anaesthetic-drugs-techniques/"/>
<updated>2026-10-28T10:36:56.498Z</updated>
<author><name>CurrentAnesthesia</name><uri>https://currentanesthesia.com/topics/anaesthetic-drugs-techniques/</uri></author>
<entry>
<title>Characteristics and Outcomes After General Anaesthesia in Elderly Patients: A Nationwide Cohort Study</title>
<id>https://currentanesthesia.com/studies/characteristics-and-outcomes-after-general-anaesthesia-in-elderly-patients-a-2026/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/characteristics-and-outcomes-after-general-anaesthesia-in-elderly-patients-a-2026/"/>
<published>2026-10-28T10:36:56.498Z</published>
<updated>2026-10-28T10:36:56.498Z</updated>
<summary>Cohort study · Acta Anaesthesiol Scand, 2026.</summary>
</entry>
<entry>
<title>Impact of additional tailored Information and music to reduce preoperative anxiety in surgical outpatients: a prospective before-after study</title>
<id>https://currentanesthesia.com/studies/impact-of-additional-tailored-information-and-music-to-reduce-preoperative-2026/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/impact-of-additional-tailored-information-and-music-to-reduce-preoperative-2026/"/>
<published>2026-10-28T04:35:18.259Z</published>
<updated>2026-10-28T04:35:18.259Z</updated>
<summary>Cohort study · Anaesth Crit Care Pain Med, 2026.</summary>
</entry>
<entry>
<title>Arterial to end-tidal CO2 gradients during isocapnic hyperventilation</title>
<id>https://currentanesthesia.com/studies/arterial-to-end-tidal-co2-gradients-during-isocapnic-hyperventilation-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/arterial-to-end-tidal-co2-gradients-during-isocapnic-hyperventilation-2022/"/>
<published>2026-10-28T04:08:44.882Z</published>
<updated>2026-10-28T04:08:44.882Z</updated>
<summary>Cohort study · J Clin Monit Comput, 2022. Pa-ETCO2 gradients: Pa-ETCO2 gradients did not change when PICO2 increased</summary>
</entry>
<entry>
<title>Development and validation of a model to calculate anesthetic agent consumption from inspired and end-expired concentrations, minute ventilation, fresh gas flow and dead space ventilation</title>
<id>https://currentanesthesia.com/studies/development-validation-model-calculate-anesthetic-agent-consumption-inspired-end-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/development-validation-model-calculate-anesthetic-agent-consumption-inspired-end-2022/"/>
<published>2026-10-28T04:08:44.882Z</published>
<updated>2026-10-28T04:08:44.882Z</updated>
<summary>Diagnostic or prognostic study · J Clin Monit Comput, 2022. Model prediction of dialed FVAP (sevoflurane, prospective testing): MDPE, median (IQR) % -1 (-11, 6) %</summary>
</entry>
<entry>
<title>Evaluation of the Temple Touch Pro™ noninvasive core-temperature monitoring system in 100 adults under general anesthesia: a prospective comparison with esophageal temperature</title>
<id>https://currentanesthesia.com/studies/evaluation-temple-touch-protm-noninvasive-core-temperature-monitoring-system-100-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/evaluation-temple-touch-protm-noninvasive-core-temperature-monitoring-system-100-2022/"/>
<published>2026-10-28T04:08:44.882Z</published>
<updated>2026-10-28T04:08:44.882Z</updated>
<summary>Cohort study · J Clin Monit Comput, 2022. Agreement of TTP vs TEso — TTP vs TEso: mean bias -0.04 °C (95% limits of agreement CI - 0.99 °C to + 0.91 °C)</summary>
</entry>
<entry>
<title>Performance of the bispectral index and electroencephalograph derived parameters of anesthetic depth during emergence from xenon and sevoflurane anesthesia</title>
<id>https://currentanesthesia.com/studies/performance-bispectral-index-electroencephalograph-derived-parameters-anesthetic-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/performance-bispectral-index-electroencephalograph-derived-parameters-anesthetic-2022/"/>
<published>2026-10-28T04:08:44.882Z</published>
<updated>2026-10-28T04:08:44.882Z</updated>
<summary>Randomised controlled trial · J Clin Monit Comput, 2022. BIS index values at emergence timepoints, First response, eyes open, removal of airway: BIS significantly lower with xenon than sevoflurane at each emergence timepoint</summary>
</entry>
<entry>
<title>Relationship between ANI and qNOX and between MAC and qCON during outpatient laparoscopic cholecystectomy using remifentanil and desflurane without muscle relaxants: a prospective observational preliminary study</title>
<id>https://currentanesthesia.com/studies/relationship-between-ani-qnox-between-mac-qcon-during-outpatient-laparoscopic-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/relationship-between-ani-qnox-between-mac-qcon-during-outpatient-laparoscopic-2022/"/>
<published>2026-10-28T04:08:44.882Z</published>
<updated>2026-10-28T04:08:44.882Z</updated>
<summary>Cohort study · J Clin Monit Comput, 2022. Relationships between monitoring indices: Poor but significant negative linear relationship between ANI and qNOX, r2 0.07</summary>
</entry>
<entry>
<title>Temperature measurements of a wearable and wireless axillary sensor iThermonitor but not a bladder probe represents the core temperature during laparoscopic rectal surgery</title>
<id>https://currentanesthesia.com/studies/temperature-measurements-wearable-wireless-axillary-sensor-ithermonitor-but-not-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/temperature-measurements-wearable-wireless-axillary-sensor-ithermonitor-but-not-2022/"/>
<published>2026-10-28T04:08:44.882Z</published>
<updated>2026-10-28T04:08:44.882Z</updated>
<summary>Research article · J Clin Monit Comput, 2022. Agreement with oesophageal temperature, whole surgical period: iThermonitor 95%; within 0.5 °C of oesophageal 95%; Lin's CCC 0.842 (95%CI: 0.831-0.851) · Bladder 84%; within 0.5 °C of oesophageal 84% (95% confidence interval 80-88%); Lin's CCC 0.688 (95%CI: 0.673-0.703)</summary>
</entry>
<entry>
<title>General Anesthetics in CAncer REsection Surgery (GA-CARES) randomized multicenter trial of propofol vs volatile inhalational anesthesia: protocol description</title>
<id>https://currentanesthesia.com/studies/general-anesthetics-in-cancer-resection-surgery-ga-cares-randomized-multicenter-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/general-anesthetics-in-cancer-resection-surgery-ga-cares-randomized-multicenter-2023/"/>
<published>2026-10-28T04:07:54.068Z</published>
<updated>2026-10-28T04:07:54.068Z</updated>
<summary>Randomised controlled trial · Perioper Med (Lond), 2023. Overall survival (assumed 5% absolute difference, 85% vs 90%), 2 years (minimum 2-year follow-up): Enrolment completed; study in follow-up phase (no results reported)</summary>
</entry>
<entry>
<title>Magnitude of early postoperative hypoxemia and its associated factors among adult patients who undergo emergency surgery under general anesthesia at Jimma Medical Center, Jimma, Southwest Ethiopia, 2021: a prospective observational study</title>
<id>https://currentanesthesia.com/studies/magnitude-early-postoperative-hypoxemia-its-associated-factors-adult-who-undergo-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/magnitude-early-postoperative-hypoxemia-its-associated-factors-adult-who-undergo-2023/"/>
<published>2026-10-28T04:07:54.068Z</published>
<updated>2026-10-28T04:07:54.068Z</updated>
<summary>Cohort study · Perioper Med (Lond), 2023. Early postoperative hypoxemia (EPH) in the PACU: Emergency surgery 149 (42.3%)</summary>
</entry>
<entry>
<title>An exploratory study of distractions during the induction phase of pediatric procedural sedation with propofol</title>
<id>https://currentanesthesia.com/studies/an-exploratory-study-of-distractions-during-the-induction-phase-of-pediatric-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/an-exploratory-study-of-distractions-during-the-induction-phase-of-pediatric-2023/"/>
<published>2026-10-28T04:04:03.147Z</published>
<updated>2026-10-28T04:04:03.147Z</updated>
<summary>Cohort study · Paediatr Anaesth, 2023. Frequency, source, target and impact of distractions during propofol induction: Total distractions 567</summary>
</entry>
<entry>
<title>Anesthetic Management of Patients With Kartagener Syndrome: A Systematic Review of 99 Cases</title>
<id>https://currentanesthesia.com/studies/anesthetic-management-of-patients-with-kartagener-syndrome-a-systematic-review-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/anesthetic-management-of-patients-with-kartagener-syndrome-a-systematic-review-2023/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Meta-analysis · J Cardiothorac Vasc Anesth, 2023. Anesthetic management of KARTAGENER SYNDROME (KS) patients: surgery type, anesthesia type, airway device, intraoperative and postoperative course: Thoracic surgery 51.5%</summary>
</entry>
<entry>
<title>Anesthetic drug shortages in Pakistan: a multicentre nationwide survey</title>
<id>https://currentanesthesia.com/studies/anesthetic-drug-shortages-in-pakistan-a-multicentre-nationwide-survey-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/anesthetic-drug-shortages-in-pakistan-a-multicentre-nationwide-survey-2022/"/>
<published>2026-10-28T03:51:30.684Z</published>
<updated>2026-10-28T03:51:30.684Z</updated>
<summary>Cross-sectional study · Can J Anaesth, 2022. Anesthetic drug shortages reported: Anesthesia practitioners reporting anesthetic drug shortages Approximately 50% (122/246)</summary>
</entry>
<entry>
<title>Comparison of visual and electromyographic assessments with train-of-four stimulation of the ulnar nerve: a prospective cohort study</title>
<id>https://currentanesthesia.com/studies/comparison-of-visual-and-electromyographic-assessments-with-train-of-four-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/comparison-of-visual-and-electromyographic-assessments-with-train-of-four-2023/"/>
<published>2026-10-28T03:51:30.684Z</published>
<updated>2026-10-28T03:51:30.684Z</updated>
<summary>Cohort study · Can J Anaesth, 2023. Subjective overestimation of the adductor pollicis response vs EMG: Subjective evaluation overestimated the response, all time points: 155/333 47%</summary>
</entry>
<entry>
<title>Efficacy of a propofol bolus against placebo to prevent cough at emergence from general anesthesia with desflurane: a randomized controlled trial</title>
<id>https://currentanesthesia.com/studies/efficacy-of-a-propofol-bolus-against-placebo-to-prevent-cough-at-emergence-from-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/efficacy-of-a-propofol-bolus-against-placebo-to-prevent-cough-at-emergence-from-2023/"/>
<published>2026-10-28T03:51:30.684Z</published>
<updated>2026-10-28T03:51:30.684Z</updated>
<summary>Randomised controlled trial · Can J Anaesth, 2023. Cough between T0 and MACage 0.15: No inferences could be drawn on cough incidence between T0 and MACage 0.15: few patients regained consciousness before MACage 0.15</summary>
</entry>
<entry>
<title>Propofol misuse in medical professions: a scoping review</title>
<id>https://currentanesthesia.com/studies/propofol-misuse-in-medical-professions-a-scoping-review-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/propofol-misuse-in-medical-professions-a-scoping-review-2022/"/>
<published>2026-10-28T03:51:30.684Z</published>
<updated>2026-10-28T03:51:30.684Z</updated>
<summary>Cohort study · Can J Anaesth, 2022. Individual demographics of those misusing propofol and outcomes of propofol misuse: Anesthesiologists and certified registered nurse anesthetists most commonly identified</summary>
</entry>
<entry>
<title>Remimazolam dose for successful insertion of a supraglottic airway device with opioids: a dose-determination study using Dixon’s up-and-down method</title>
<id>https://currentanesthesia.com/studies/remimazolam-dose-for-successful-insertion-of-a-supraglottic-airway-device-with-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/remimazolam-dose-for-successful-insertion-of-a-supraglottic-airway-device-with-2022/"/>
<published>2026-10-28T03:51:30.684Z</published>
<updated>2026-10-28T03:51:30.684Z</updated>
<summary>Cohort study · Can J Anaesth, 2022. Remimazolam dose for successful i-gel insertion: ED50 8.8 mg·kg-1·hr-1 8.8 (95% CI 6.3 to 10.6)</summary>
</entry>
<entry>
<title>Effect of midazolam in autism spectrum disorder: A retrospective observational analysis</title>
<id>https://currentanesthesia.com/studies/effect-of-midazolam-in-autism-spectrum-disorder-a-retrospective-observational-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/effect-of-midazolam-in-autism-spectrum-disorder-a-retrospective-observational-2023/"/>
<published>2026-10-28T03:44:37.230Z</published>
<updated>2026-10-28T03:44:37.230Z</updated>
<summary>Cohort study · Acta Anaesthesiol Scand, 2023. Factors associated with Observer's Assessment of Alertness/Sedation score, 30 min after premedication: Age, OR (95% CI 1.213-1.708), P &lt; .001 1.437</summary>
</entry>
<entry>
<title>Pre‐anaesthetic assessment and related outcome measures in adults undergoing elective surgery—Scoping review protocol</title>
<id>https://currentanesthesia.com/studies/pre-anaesthetic-assessment-and-related-outcome-measures-in-adults-undergoing-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/pre-anaesthetic-assessment-and-related-outcome-measures-in-adults-undergoing-2023/"/>
<published>2026-10-28T03:44:37.230Z</published>
<updated>2026-10-28T03:44:37.230Z</updated>
<summary>Trial design · Acta Anaesthesiol Scand, 2023.</summary>
</entry>
<entry>
<title>The effect of ketamine and fentanyl on haemodynamics during intubation in pre‐hospital and retrieval medicine</title>
<id>https://currentanesthesia.com/studies/the-effect-of-ketamine-and-fentanyl-on-haemodynamics-during-intubation-in-pre-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/the-effect-of-ketamine-and-fentanyl-on-haemodynamics-during-intubation-in-pre-2022/"/>
<published>2026-10-28T03:44:37.230Z</published>
<updated>2026-10-28T03:44:37.230Z</updated>
<summary>Cohort study · Acta Anaesthesiol Scand, 2022. SBP outside pre-specified target range within 10 min of induction, adjusted for baseline abnormality, within 10 min of anaesthetic induction: Fentanyl use not associated with a change in odds of meeting the primary outcome (OR, 95% CI) OR 1.08; 95% CI 0.72-1.60</summary>
</entry>
<entry>
<title>A randomized, controlled clinical trial comparing remimazolam to propofol when combined with alfentanil for sedation during ERCP procedures</title>
<id>https://currentanesthesia.com/studies/a-randomized-controlled-clinical-trial-comparing-remimazolam-to-propofol-when-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/a-randomized-controlled-clinical-trial-comparing-remimazolam-to-propofol-when-2023/"/>
<published>2026-10-28T03:40:44.883Z</published>
<updated>2026-10-28T03:40:44.883Z</updated>
<summary>Randomised controlled trial · J Clin Anesth, 2023. Hypoxia (SpO2 &lt; 90% for &gt;10 s), During ERCP: Remimazolam 9.6% · Propofol 15.7%</summary>
</entry>
<entry>
<title>Efficacy and safety of Ciprofol for procedural sedation and anesthesia in non-operating room settings</title>
<id>https://currentanesthesia.com/studies/efficacy-and-safety-of-ciprofol-for-procedural-sedation-and-anesthesia-in-non-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/efficacy-and-safety-of-ciprofol-for-procedural-sedation-and-anesthesia-in-non-2023/"/>
<published>2026-10-28T03:40:44.883Z</published>
<updated>2026-10-28T03:40:44.883Z</updated>
<summary>Randomised controlled trial · J Clin Anesth, 2023. Procedure success rate: Ciprofol 6 mg/kg/h 100% · Ciprofol 8 mg/kg/h 100% · Propofol 100%</summary>
</entry>
<entry>
<title>Hypoventilation in the PACU is associated with hypoventilation in the surgical ward: Post-hoc analysis of a randomized clinical trial</title>
<id>https://currentanesthesia.com/studies/hypoventilation-in-the-pacu-is-associated-with-hypoventilation-in-the-surgical-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/hypoventilation-in-the-pacu-is-associated-with-hypoventilation-in-the-surgical-2022/"/>
<published>2026-10-28T03:40:44.883Z</published>
<updated>2026-10-28T03:40:44.883Z</updated>
<summary>Secondary analysis · J Clin Anesth, 2022. Low MV events lasting ≥2 min in the surgical ward, rest of the first 48 postoperative hours: Low MV event in PACU 20 · No low MV event in PACU 61 (22%)</summary>
</entry>
<entry>
<title>Unwanted spontaneous responsiveness and burst suppression in patients undergoing entropy-guided total intravenous anesthesia with target-controlled infusion: An observational prospective trial</title>
<id>https://currentanesthesia.com/studies/unwanted-spontaneous-responsiveness-burst-suppression-undergoing-entropy-guided-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/unwanted-spontaneous-responsiveness-burst-suppression-undergoing-entropy-guided-2023/"/>
<published>2026-10-28T03:40:44.883Z</published>
<updated>2026-10-28T03:40:44.883Z</updated>
<summary>Cohort study · J Clin Anesth, 2023. Incidence of unwanted spontaneous responsiveness and burst suppression (BSupp): Unwanted spontaneous responsiveness 13.1%</summary>
</entry>
<entry>
<title>Efficacy and safety of ciprofol vs. propofol for the induction and maintenance of general anaesthesia: A multicentre, single-blind, randomised, parallel-group, phase 3 clinical trial</title>
<id>https://currentanesthesia.com/studies/efficacy-and-safety-of-ciprofol-vs-propofol-for-the-induction-and-maintenance-of-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/efficacy-and-safety-of-ciprofol-vs-propofol-for-the-induction-and-maintenance-of-2023/"/>
<published>2026-10-28T03:35:32.861Z</published>
<updated>2026-10-28T03:35:32.861Z</updated>
<summary>Randomised controlled trial · Eur J Anaesthesiol, 2023. Success rate of anaesthetic maintenance (noninferiority: lower limit of 95% CI for between-group difference &gt;-8%): HSK3486 100% · Propofol 100%</summary>
</entry>
<entry>
<title>Peri-operative management of neuromuscular blockade: A guideline from the European Society of Anaesthesiology and Intensive Care</title>
<id>https://currentanesthesia.com/studies/peri-operative-management-of-neuromuscular-blockade-a-guideline-from-the-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/peri-operative-management-of-neuromuscular-blockade-a-guideline-from-the-2022/"/>
<published>2026-10-28T03:35:32.861Z</published>
<updated>2026-10-28T03:35:32.861Z</updated>
<summary>Guideline or statement · Eur J Anaesthesiol, 2022.</summary>
</entry>
<entry>
<title>A Pilot Investigation Evaluating Relative Changes in Fronto-Occipital Alpha and Beta Spectral Power as Measurement of Anesthesia Hypnotic Depth</title>
<id>https://currentanesthesia.com/studies/a-pilot-investigation-evaluating-relative-changes-in-fronto-occipital-alpha-and-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/a-pilot-investigation-evaluating-relative-changes-in-fronto-occipital-alpha-and-2023/"/>
<published>2026-10-28T03:28:59.708Z</published>
<updated>2026-10-28T03:28:59.708Z</updated>
<summary>Cohort study · Anesth Analg, 2023. FO-RPAB shift: Significant FO-RPAB shift during both induction of and emergence from GA P &lt; .001</summary>
</entry>
<entry>
<title>Oral Dantrolene for Myopathic Symptoms in Malignant Hyperthermia–Susceptible Patients: A 25-Year Retrospective Cohort Study of Adverse Effects and Tolerability</title>
<id>https://currentanesthesia.com/studies/oral-dantrolene-myopathic-symptoms-malignant-hyperthermia-susceptible-25-year-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/oral-dantrolene-myopathic-symptoms-malignant-hyperthermia-susceptible-25-year-2022/"/>
<published>2026-10-28T03:28:59.708Z</published>
<updated>2026-10-28T03:28:59.708Z</updated>
<summary>Cohort study · Anesth Analg, 2022. Serious adverse effects: No serious adverse effects reported</summary>
</entry>
<entry>
<title>Performance of the SEDLine Monitor: Age Dependency and Time Delay</title>
<id>https://currentanesthesia.com/studies/performance-of-the-sedline-monitor-age-dependency-and-time-delay-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/performance-of-the-sedline-monitor-age-dependency-and-time-delay-2023/"/>
<published>2026-10-28T03:28:59.708Z</published>
<updated>2026-10-28T03:28:59.708Z</updated>
<summary>Mechanistic study · Anesth Analg, 2023. Influence of patient's age and time delay on the patient state index (PSI) of the SEDLine monitor: PSI and spectral edge frequency (SEF) increased significantly with patient's age; independent of anesthetic administered</summary>
</entry>
<entry>
<title>Postoperative Risk of Transfusion After Reversal of Residual Neuromuscular Block With Sugammadex Versus Neostigmine: A Retrospective Cohort Study</title>
<id>https://currentanesthesia.com/studies/postoperative-risk-of-transfusion-after-reversal-of-residual-neuromuscular-block-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/postoperative-risk-of-transfusion-after-reversal-of-residual-neuromuscular-block-2023/"/>
<published>2026-10-28T03:28:59.708Z</published>
<updated>2026-10-28T03:28:59.708Z</updated>
<summary>Cohort study · Anesth Analg, 2023. Any postoperative transfusion of RBC, and/or FFP, and/or platelets: Sugammadex 8.01% · Neostigmine 7.38%</summary>
</entry>
<entry>
<title>Reducing Volatile Anesthetic Waste Using a Commercial Electronic Health Record Clinical Decision Support Tool to Lower Fresh Gas Flows</title>
<id>https://currentanesthesia.com/studies/reducing-volatile-anesthetic-waste-using-a-commercial-electronic-health-record-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/reducing-volatile-anesthetic-waste-using-a-commercial-electronic-health-record-2022/"/>
<published>2026-10-28T03:28:59.708Z</published>
<updated>2026-10-28T03:28:59.708Z</updated>
<summary>Research article · Anesth Analg, 2022. Mean FGF (L/min) and volatile agent consumption (mL/MAC-h), segmented regression of interrupted time series, immediately after implementation of the intervention: Decrease in mean FGF, sevoflurane 0.6 L/min (95% CI, 0.6-0.6 L/min; P &lt; .0001)</summary>
</entry>
<entry>
<title>Sugammadex Versus Neostigmine for Recovery of Respiratory Muscle Strength Measured by Ultrasonography in the Postextubation Period: A Randomized Controlled Trial</title>
<id>https://currentanesthesia.com/studies/sugammadex-neostigmine-recovery-respiratory-muscle-strength-measured-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/sugammadex-neostigmine-recovery-respiratory-muscle-strength-measured-2022/"/>
<published>2026-10-28T03:28:59.708Z</published>
<updated>2026-10-28T03:28:59.708Z</updated>
<summary>Randomised controlled trial · Anesth Analg, 2022. Change in thickening fraction of internal oblique abdominal muscle (TF IO, expiratory muscle strength, ultrasonography) from baseline, TOFR ≥0.9: Sugammadex mean 9% ± 6% · Neostigmine mean 16% ± 9%</summary>
</entry>
<entry>
<title>A prospective observational study of the effects of sugammadex on peri‐operative oestrogen and progesterone levels in women who take hormonal contraception</title>
<id>https://currentanesthesia.com/studies/a-prospective-observational-study-of-the-effects-of-sugammadex-on-peri-operative-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/a-prospective-observational-study-of-the-effects-of-sugammadex-on-peri-operative-2022/"/>
<published>2026-10-28T03:25:23.999Z</published>
<updated>2026-10-28T03:25:23.999Z</updated>
<summary>Cohort study · Anaesthesia, 2022. Serum oestrogen and progesterone levels: Median oestrogen decreased from baseline by around 40% at 240 min in all three groups p ≤ 0.001</summary>
</entry>
<entry>
<title>Effect of high‐flow nasal oxygen on hypoxaemia during procedural sedation: a systematic review and meta‐analysis</title>
<id>https://currentanesthesia.com/studies/effect-of-high-flow-nasal-oxygen-on-hypoxaemia-during-procedural-sedation-a-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/effect-of-high-flow-nasal-oxygen-on-hypoxaemia-during-procedural-sedation-a-2022/"/>
<published>2026-10-28T03:25:23.999Z</published>
<updated>2026-10-28T03:25:23.999Z</updated>
<summary>Meta-analysis · Anaesthesia, 2022. Hypoxaemia — HFNO vs Conventional oxygen therapy: RR 0.37 (95% CI 0.24-0.56); p &lt; 0.001</summary>
</entry>
<entry>
<title>The effects of sugammadex vs. neostigmine on postoperative respiratory complications and advanced healthcare utilisation: a multicentre retrospective cohort study</title>
<id>https://currentanesthesia.com/studies/effects-sugammadex-neostigmine-postoperative-respiratory-complications-advanced-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/effects-sugammadex-neostigmine-postoperative-respiratory-complications-advanced-2022/"/>
<published>2026-10-28T03:25:23.999Z</published>
<updated>2026-10-28T03:25:23.999Z</updated>
<summary>Cohort study · Anaesthesia, 2022. Postoperative respiratory complications (post-extubation SpO2 &lt; 90%, respiratory failure requiring NIV, or tracheal re-intubation), within 7 days — Sugammadex vs Neostigmine: aOR 1.01 (95% CI 0.94-1.08); p = 0.76</summary>
</entry>
<entry>
<title>Breathe–squeeze: pharmacodynamics of a stimulus-free behavioural paradigm to track conscious states during sedation☆</title>
<id>https://currentanesthesia.com/studies/breathe-squeeze-pharmacodynamics-of-a-stimulus-free-behavioural-paradigm-to-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/breathe-squeeze-pharmacodynamics-of-a-stimulus-free-behavioural-paradigm-to-2023/"/>
<published>2026-10-28T03:18:44.786Z</published>
<updated>2026-10-28T03:18:44.786Z</updated>
<summary>Secondary analysis · Br J Anaesth, 2023. Estimated dexmedetomidine Ce: LOR mean 0.92 (95% CI 0.69-1.15) ng ml-1 · ROR mean 1.43 (95% CI 1.27-1.58) ng ml-1</summary>
</entry>
<entry>
<title>Comparison of the effects of sugammadex versus neostigmine for reversal of neuromuscular block on hospital costs of care</title>
<id>https://currentanesthesia.com/studies/comparison-of-the-effects-of-sugammadex-versus-neostigmine-for-reversal-of-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/comparison-of-the-effects-of-sugammadex-versus-neostigmine-for-reversal-of-2022/"/>
<published>2026-10-28T03:18:44.786Z</published>
<updated>2026-10-28T03:18:44.786Z</updated>
<summary>Cohort study · Br J Anaesth, 2022. Direct costs (registry data) — Sugammadex vs Neostigmine: difference -1.3 % (95% CI -0.5 to -2.2%); P=0.002; lower costs</summary>
</entry>
<entry>
<title>Connected consciousness after tracheal intubation in young adults: an international multicentre cohort study</title>
<id>https://currentanesthesia.com/studies/connected-consciousness-after-tracheal-intubation-in-young-adults-an-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/connected-consciousness-after-tracheal-intubation-in-young-adults-an-2022/"/>
<published>2026-10-28T03:18:44.786Z</published>
<updated>2026-10-28T03:18:44.786Z</updated>
<summary>Cohort study · Br J Anaesth, 2022. Connected consciousness (response to command) after tracheal intubation: Responses after intubation 37/338 subjects (11%)</summary>
</entry>
<entry>
<title>Dementia risk amongst older adults with hip fracture receiving general anaesthesia or regional anaesthesia: a propensity-score-matched population-based cohort study</title>
<id>https://currentanesthesia.com/studies/dementia-risk-amongst-older-adults-hip-fracture-receiving-general-anaesthesia-or-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/dementia-risk-amongst-older-adults-hip-fracture-receiving-general-anaesthesia-or-2022/"/>
<published>2026-10-28T03:18:44.786Z</published>
<updated>2026-10-28T03:18:44.786Z</updated>
<summary>Cohort study · Br J Anaesth, 2022. Dementia incidence rate: Inhalational GA incidence rate 4821 per 100 000 person-years · TIVA-GA incidence rate 3400 per 100 000 person-years · RA incidence rate 2692 per 100 000 person-years</summary>
</entry>
<entry>
<title>Depth of anaesthesia and mortality after cardiac or noncardiac surgery: a systematic review and meta-analysis of randomised controlled trials</title>
<id>https://currentanesthesia.com/studies/depth-of-anaesthesia-and-mortality-after-cardiac-or-noncardiac-surgery-a-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/depth-of-anaesthesia-and-mortality-after-cardiac-or-noncardiac-surgery-a-2022/"/>
<published>2026-10-28T03:18:44.786Z</published>
<updated>2026-10-28T03:18:44.786Z</updated>
<summary>Meta-analysis · Br J Anaesth, 2022. Mortality, all studies pooled — Light anaesthesia vs Deep anaesthesia: OR 0.99 (95% CI 0.92-1.08)</summary>
</entry>
<entry>
<title>Processed electroencephalography-guided general anaesthesia to reduce postoperative delirium: a systematic review and meta-analysis</title>
<id>https://currentanesthesia.com/studies/processed-electroencephalography-guided-general-anaesthesia-reduce-postoperative-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/processed-electroencephalography-guided-general-anaesthesia-reduce-postoperative-2022/"/>
<published>2026-10-28T03:18:44.786Z</published>
<updated>2026-10-28T03:18:44.786Z</updated>
<summary>Meta-analysis · Br J Anaesth, 2022. POD assessed by validated tools: pEEG-guided GA or lighter pEEG target 440 (19.0%) · Usual care or deeper pEEG target 545 (23.3%)</summary>
</entry>
<entry>
<title>Sevoflurane dose and postoperative delirium: a prospective cohort analysis</title>
<id>https://currentanesthesia.com/studies/sevoflurane-dose-and-postoperative-delirium-a-prospective-cohort-analysis-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/sevoflurane-dose-and-postoperative-delirium-a-prospective-cohort-analysis-2022/"/>
<published>2026-10-28T03:18:44.786Z</published>
<updated>2026-10-28T03:18:44.786Z</updated>
<summary>Cohort study · Br J Anaesth, 2022. Delirium severity: Correlation with AMS (Spearman's ρ) -0.014, P=0.89</summary>
</entry>
<entry>
<title>The posterior dominant rhythm: an electroencephalographic biomarker for cognitive recovery after general anaesthesia</title>
<id>https://currentanesthesia.com/studies/the-posterior-dominant-rhythm-an-electroencephalographic-biomarker-for-cognitive-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/the-posterior-dominant-rhythm-an-electroencephalographic-biomarker-for-cognitive-2022/"/>
<published>2026-10-28T03:18:44.786Z</published>
<updated>2026-10-28T03:18:44.786Z</updated>
<summary>Secondary analysis · Br J Anaesth, 2022. posterior dominant rhythm (PDR) peak frequency (change from pre-intervention baseline): Control median difference 0.02 (IQR 0.20) Hz · Isoflurane median difference 0.88 (IQR 0.65) Hz</summary>
</entry>
<entry>
<title>2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade: A Report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade</title>
<id>https://currentanesthesia.com/studies/2023-american-society-anesthesiologists-practice-guidelines-monitoring-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/2023-american-society-anesthesiologists-practice-guidelines-monitoring-2023/"/>
<published>2026-10-28T03:16:58.759Z</published>
<updated>2026-10-28T03:16:58.759Z</updated>
<summary>Guideline or statement · Anesthesiology, 2023.</summary>
</entry>
<entry>
<title>Comparison of Contralateral Acceleromyography and Electromyography for Posttetanic Count Measurement</title>
<id>https://currentanesthesia.com/studies/comparison-of-contralateral-acceleromyography-and-electromyography-for-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/comparison-of-contralateral-acceleromyography-and-electromyography-for-2022/"/>
<published>2026-10-28T03:16:58.759Z</published>
<updated>2026-10-28T03:16:58.759Z</updated>
<summary>Research article · Anesthesiology, 2022. Agreement of NMB status (intense or deep block): Percentage agreement of NMB status 73%</summary>
</entry>
<entry>
<title>Propofol and survival: an updated meta-analysis of randomized clinical trials</title>
<id>https://currentanesthesia.com/studies/propofol-and-survival-an-updated-meta-analysis-of-randomized-clinical-trials-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/propofol-and-survival-an-updated-meta-analysis-of-randomized-clinical-trials-2023/"/>
<published>2026-10-27T23:14:23.345Z</published>
<updated>2026-10-27T23:14:23.345Z</updated>
<summary>Meta-analysis · Crit Care, 2023. Mortality at the longest follow-up available, longest follow-up available: Propofol 760 (5.2%) · Comparator 682 (4.3%)</summary>
</entry>
<entry>
<title>Evaluation of patient state index, bispectral index, and entropy during drug induced sleep endoscopy with dexmedetomidine</title>
<id>https://currentanesthesia.com/studies/evaluation-of-patient-state-index-bispectral-index-and-entropy-during-drug-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/evaluation-of-patient-state-index-bispectral-index-and-entropy-during-drug-2022/"/>
<published>2026-10-27T23:08:04.173Z</published>
<updated>2026-10-27T23:08:04.173Z</updated>
<summary>Cohort study · J Clin Monit Comput, 2022. Association with RASS score: PSI, BIS and Entropy each significantly associated with RASS score p &lt; 0.001 for all metrics</summary>
</entry>
<entry>
<title>Performance of a new auxiliary device based on wrist brace to improve accuracy and feasibility in neuromuscular monitoring with acceleromyography in prone-positioned patients undergoing lumbar spine surgery: a prospective randomized clinical trial</title>
<id>https://currentanesthesia.com/studies/performance-new-auxiliary-device-based-wrist-brace-improve-accuracy-feasibility-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/performance-new-auxiliary-device-based-wrist-brace-improve-accuracy-feasibility-2023/"/>
<published>2026-10-27T23:08:04.173Z</published>
<updated>2026-10-27T23:08:04.173Z</updated>
<summary>Randomised controlled trial · J Clin Monit Comput, 2023. Repeatability coefficient of T1, recovery to T1 of 25% and TOF ratio of 0.9: Repeatability coefficient of T1 significantly lower in B (higher precision), recovery to T1 25% P = 0.017</summary>
</entry>
<entry>
<title>Quantitative relationship between anteriorization of alpha oscillations and level of general anesthesia</title>
<id>https://currentanesthesia.com/studies/quantitative-relationship-between-anteriorization-of-alpha-oscillations-and-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/quantitative-relationship-between-anteriorization-of-alpha-oscillations-and-2022/"/>
<published>2026-10-27T23:08:04.173Z</published>
<updated>2026-10-27T23:08:04.173Z</updated>
<summary>Cohort study · J Clin Monit Comput, 2022. Spearman correlation (mean of Fisher transformations) with BIS value: Frontal alpha power vs BIS, 95% CI - 0.68, - 0.26</summary>
</entry>
<entry>
<title>Relationships between common carotid artery blood flow and anesthesia, pneumoperitoneum, and head-down tilt position: a linear mixed-effect analysis</title>
<id>https://currentanesthesia.com/studies/relationships-between-common-carotid-artery-blood-flow-anesthesia-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/relationships-between-common-carotid-artery-blood-flow-anesthesia-2022/"/>
<published>2026-10-27T23:08:04.173Z</published>
<updated>2026-10-27T23:08:04.173Z</updated>
<summary>Cohort study · J Clin Monit Comput, 2022. CCA blood flow: T1 345.4 (range 288.0-392.9) · T2 293.1 (range 253.0-342.6) · T3 283.6 (range 258.8-307.6) · T4 287.1 (range 242.1-321.4)</summary>
</entry>
</feed>
